NCT03796182View on ClinicalTrials.gov

Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

February 13, 2019

Study Completion Date

March 12, 2019

Conditions
Healthy
Interventions
DRUG

Metformin

Commercially available metformin (GLUCOPHAGE®) as 500 mg tablets.

DRUG

PF-04965842

PF 04965842 100 mg tablets

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03796182 - Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants | Biotech Hunter | Biotech Hunter